Heron Therapeutics, Inc. (HRTX)
USD 1.57
(-4.85%)
USD 1.57
(-4.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Total Assets | 222.5 Million | 250.95 Million | 305.7 Million | 353.55 Million | 512.78 Million | 462.17 Million |
| Total Current Assets | 188.77 Million | 205.43 Million | 254.42 Million | 314.19 Million | 479.06 Million | 447.24 Million |
| Cash And Short Term Investments | 80.4 Million | 84.85 Million | 157.58 Million | 208.49 Million | 390.97 Million | 332.37 Million |
| Cash and Cash Equivalents | 28.67 Million | 15.36 Million | 90.54 Million | 105.13 Million | 71.89 Million | 31.83 Million |
| Short Term Investments | 51.73 Million | 69.48 Million | 67.03 Million | 103.35 Million | 319.07 Million | 300.53 Million |
| Net Receivables | 60.13 Million | 52.04 Million | 35.49 Million | 41.85 Million | 39.87 Million | 64.65 Million |
| Inventory | 42.11 Million | 54.57 Million | 48.38 Million | 41.9 Million | 24.96 Million | 39.03 Million |
| Other Current Assets | 6.11 Million | 13.96 Million | 12.96 Million | 21.95 Million | 23.24 Million | 11.19 Million |
| Total Non-Current Assets | 33.73 Million | 45.51 Million | 51.28 Million | 39.36 Million | 33.71 Million | 14.93 Million |
| Net PPE | 25.6 Million | 29.8 Million | 33.56 Million | 39.01 Million | 33.37 Million | 14.67 Million |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | 8.12 Million | 15.71 Million | 17.72 Million | 346 Thousand | 346 Thousand | 254 Thousand |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 256.47 Million | 237.37 Million | 228.13 Million | 117.06 Million | 108.94 Million | 92.01 Million |
| Total Current Liabilities | 79.68 Million | 82.35 Million | 71.05 Million | 102.5 Million | 96.7 Million | 92.01 Million |
| Account Payables | 3.24 Million | 3.22 Million | 3.8 Million | 525 Thousand | 2.75 Million | 17.08 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 3.07 Million | 2.69 Million | 2.41 Million | 10.05 Million | 7.55 Million | 4.57 Million |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 73.37 Million | 76.43 Million | 64.83 Million | 91.92 Million | 86.39 Million | 70.35 Million |
| Total Non Current Liabilities | 176.79 Million | 155.02 Million | 157.07 Million | 14.56 Million | 12.24 Million | - |
| Long-Term Debt | 173.75 Million | 154.78 Million | 157.07 Million | 14.56 Million | 12.24 Million | - |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 3.04 Million | 241 Thousand | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | -33.97 Million | 13.57 Million | 77.57 Million | 236.49 Million | 403.83 Million | 370.16 Million |
| Stock Holders Equity | -33.97 Million | 13.57 Million | 77.57 Million | 236.49 Million | 403.83 Million | 370.16 Million |
| Common Stock | 1.5 Million | 1.19 Million | 1.02 Million | 913 Thousand | 903 Thousand | 782 Thousand |
| Retained Earnings | -1.9 Billion | -1.79 Billion | -1.61 Billion | -1.39 Billion | -1.16 Billion | -960.72 Million |
| Accumulated other comprehensive income | 13 Thousand | -19 Thousand | -6000.00 | 257 Thousand | 85 Thousand | -87 Thousand |
| Common Stock Equity | -33.97 Million | 13.57 Million | 77.57 Million | 236.49 Million | 403.83 Million | 370.16 Million |
| Capital Lease Obligation | 2.8 Million | 8.19 Million | 10.41 Million | 17.55 Million | 14.16 Million | - |
| Total Investments | 51.73 Million | 69.48 Million | 67.03 Million | 103.35 Million | 319.07 Million | 300.53 Million |
| Total Debt | 179.62 Million | 157.47 Million | 159.49 Million | 24.61 Million | 19.79 Million | 4.57 Million |
| Net Debt | 150.95 Million | 142.11 Million | 68.95 Million | -80.52 Million | -52.1 Million | -27.26 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | 218.13 Million | 217.88 Million | 222.5 Million | 222.5 Million | 229.19 Million | 201.22 Million |
| Total Current Assets | 191.16 Million | 185.9 Million | 188.77 Million | 188.77 Million | 193.97 Million | 165.28 Million |
| Cash And Short Term Investments | 67.34 Million | 71.52 Million | 80.4 Million | 80.4 Million | 77.41 Million | 33.24 Million |
| Cash and Cash Equivalents | 18.38 Million | 20.45 Million | 28.67 Million | 28.67 Million | 34.85 Million | 13.46 Million |
| Short Term Investments | 48.96 Million | 51.07 Million | 51.73 Million | 51.73 Million | 42.55 Million | 19.78 Million |
| Net Receivables | 73.7 Million | 65.32 Million | 60.13 Million | 60.13 Million | 63.79 Million | 76.69 Million |
| Inventory | 42.86 Million | 42.47 Million | 42.11 Million | 42.11 Million | 42 Million | 44.62 Million |
| Other Current Assets | 7.24 Million | 6.58 Million | 6.11 Million | 6.11 Million | 10.76 Million | 10.72 Million |
| Total Non-Current Assets | 26.96 Million | 31.98 Million | 33.73 Million | 33.73 Million | 35.22 Million | 35.94 Million |
| Net PPE | 20.03 Million | 24.1 Million | 25.6 Million | 25.6 Million | 26.85 Million | 27.36 Million |
| Good Will And Intangible Assets | - | - | - | - | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - | - |
| Long-Term Investments | - | - | - | - | - | - |
| Tax Assets | - | - | - | - | - | - |
| Other Non Current Assets | 6.92 Million | 7.88 Million | 8.12 Million | 8.12 Million | 8.36 Million | 8.58 Million |
| Other Assets | 1.00 | - | - | - | - | - |
| Total Liabilities | 256.07 Million | 251.65 Million | 256.47 Million | 256.47 Million | 256.98 Million | 240.5 Million |
| Total Current Liabilities | 80.31 Million | 75.37 Million | 79.68 Million | 79.68 Million | 79.74 Million | 86.72 Million |
| Account Payables | 10.22 Million | 837 Thousand | 3.24 Million | 3.24 Million | 1.86 Million | 1.95 Million |
| Tax Payables | - | - | - | - | - | - |
| Short Term Debt | 3.19 Million | 3.13 Million | 3.07 Million | 3.07 Million | 2.99 Million | 2.58 Million |
| Deferred Revenue | - | - | - | - | - | - |
| Other Current Liabilities | 66.89 Million | 71.4 Million | 73.37 Million | 73.37 Million | 74.88 Million | 82.18 Million |
| Total Non Current Liabilities | 175.75 Million | 176.27 Million | 176.79 Million | 176.79 Million | 177.24 Million | 153.78 Million |
| Long-Term Debt | 174.22 Million | 173.98 Million | 173.75 Million | 173.75 Million | 176.99 Million | 153.54 Million |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 1.53 Million | 2.28 Million | 3.04 Million | 3.04 Million | 241 Thousand | 241 Thousand |
| Other Liabilities | - | 1.00 | - | - | - | - |
| Total Equity | -37.94 Million | -33.76 Million | -33.97 Million | -33.97 Million | -27.78 Million | -39.28 Million |
| Stock Holders Equity | -37.94 Million | -33.76 Million | -33.97 Million | -33.97 Million | -27.78 Million | -39.28 Million |
| Common Stock | 1.51 Million | 1.5 Million | 1.5 Million | 1.5 Million | 1.41 Million | 1.19 Million |
| Retained Earnings | -1.91 Billion | -1.9 Billion | -1.9 Billion | -1.9 Billion | -1.89 Billion | -1.87 Billion |
| Accumulated other comprehensive income | -8000.00 | -6000.00 | 13 Thousand | 13 Thousand | -1000.00 | -6000.00 |
| Common Stock Equity | -37.94 Million | -33.76 Million | -33.97 Million | -33.97 Million | -27.78 Million | -39.28 Million |
| Capital Lease Obligation | 1.28 Million | 2.04 Million | 2.8 Million | 2.8 Million | 6.53 Million | 6.73 Million |
| Total Investments | 48.96 Million | 51.07 Million | 51.73 Million | 51.73 Million | 42.55 Million | 19.78 Million |
| Total Debt | 178.71 Million | 179.17 Million | 179.62 Million | 179.62 Million | 179.99 Million | 156.12 Million |
| Net Debt | 160.32 Million | 158.72 Million | 150.95 Million | 150.95 Million | 145.13 Million | 142.66 Million |
4987
NHMAF
SNPHF
9938
AUB
BE